Survivors of childhood cancer: Long-term endocrine and metabolic problems dwarf the growth disturbance

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 433, 1999, Pages 5-12

  Murray, R D ^a   Brennan, B M D ^a   Rahim, A ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Childhood malignancy; Growth hormone deficiency; Long term survivors

Indexed keywords

ANTINEOPLASTIC AGENT;

BODY HEIGHT; BODY MASS; BONE DENSITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILDHOOD CANCER; CONFERENCE PAPER; DWARFISM; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH RATE; GROWTH RETARDATION; HUMAN; LEAN BODY WEIGHT; MUSCLE STRENGTH; OBESITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; BODY COMPOSITION; BONE DENSITY; BRAIN; CHILD; GROWTH DISORDERS; HUMANS; NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY; SURVIVORS; TIME FACTORS;

EID: 0033436283     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Adan L, Souberbielle JC, Blanche S, Leverger G, Schaison G, Brauner R. Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta Paediatr 1996; 85: 1096-101
2. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK, Shalet SM. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Arch Dis Child 1994; 70: 472-5
3. Shalet SM, Beardwell CG, Aarons BM, Pearson D, Jones PH. Growth impairment in children treated for brain tumours. Arch Dis Child 1978; 53: 491-4
4. Ogilvy-Stuart AL, Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child 1995; 73: 141-6
5. Olshan JS, Gubernick J, Packer RJ, D'Angio GJ, Goldwein JW, Willi SM, et al. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 1992; 70: 2013-7
6. Nivot S, Benelli C, Clot JP, Saucet C, Adan L, Souberbielle JC, et al. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy. I Clin Endocrinol Metab 1994; 78: 597-601
7. Shalet SM, Whitehead E, Chapman AJ, Beardwell CG. The effects of growth hormone therapy in children with radiation-induced growth hormone deficiency. Acta Paediatr Scand 1981; 70: 81-6
8. Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 1992; 10: 128-33
9. Talvensaari KK, Jamsen A, Vanharanta H, Lanning M. Decreased isokinetic trunk muscle strength and performance in long-term survivors of childhood malignancies: correlation with hormonal defects. Arch Phys Med Rehabil 1995; 76: 983-8
10. Sainsbury CP, Newcombe RG, Hughes IA. Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukeamia. Arch Dis Child 1985; 60: 832-6
11. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr 1995; 127: 63-7
12. Gilsanz V, Carlson ME, Roe TF, Ortega JA. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990; 117: 238-44
13. Hoorweg-Nijman JJ, Kardos G, Roos JC, van Dijk HJ, Netelenbos C, Popp-Snijders C, et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol (Oxf) 1999; 50: 237-44
14. Aisenberg J, Hsieh K, Kalaitzoglou G, Whittam E, Heller G, Schneider R, et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol 1998; 20: 241-5
15. Herold AH, Roetzheim RG. Cancer survivors. Prim Care 1992; 19: 779-91
16. Mostow EN, Byrne J, Connelly RR, Mulvihill JJ. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 1991; 9: 592-9
17. Seaver E, Geyer R, Sulzbacher S, Warner M, Batzel L, Milstein J, et al. Psychosocial adjustment in long-term survivors of childhood medulloblastoma and ependymoma treated with craniospinal irradiation. Pediatr Neurosurg 1994; 20: 248-53
18. Freeman CR, Bourgoiuin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 1996; 77: 555-62
19. Yamamoto M, Fukunaga Y, Tsukimoto I, Bessho F, Akatsuka J, Hosoya R, et al. Late effects of childhood acute leukemia and its treatment. Acta Paediatr Jpn 1991; 33: 573-88
20. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998; 16: 1723-8
21. Packer RJ, Meadows AT, Rorke LB, Goldwein JL, D'Angio G. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 1987; 15: 241-53
22. Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997; 89: 1886-95
23. Talvensaari KK, Lanning M, Tapanainen P, Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996; 81: 3051-5
24. Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf) 1998; 48: 777-83
25. Achermann JC, Hindmarsh PC, Brook CGD. Severe growth hormone (GH) insufficiency persists in adults after high dose cranial irradiation for brain tumours in childhood. Endocrinol Metab 1996; 4(Suppl A): 54
26. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) 1989; 31: 363-73
27. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group, J Clin Endocrinol Metab 1997; 82: 82-8
28. Longobardi S, Cuocolo A, Merola B, Di Rella F, Colao A, Nicolai E, et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf) 1998; 48: 137-43
29. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992; 74: 118-23
30. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol (Oxf) 1991; 34: 469-75
31. Rosen T, Bengtsson BÅ. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-8
32. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996; 81: 1169-72
33. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, et al. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 1378-81
34. Carroll PV, Christ ER, Bengtsson BÅ, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998; 83: 382-95
35. Johansson JO, Landin K, Tengborn L, Rosén T, Bengtsson BÅ. High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 1994; 14: 434-7
36. Brennan BM, Raham A, Adams JA, Eden OB, Shalet SM. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer 1999; 79: 1859-63
37. Brennan BM, Rahim A, Blum WF, Adams JA, Eden OB, Shalet SM. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol (Oxf) 1999; 50: 163-69
38. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM. Dose titration and patient selection increases the efficacy of GH replacement in GHD adults. Clin Endocrinol (Oxf) 1999; 50: 749-57
39. Wiren L, Willhemsen L, McKenna S, Hernberg-Ståhl E. Quality of life of adult patients with growth hormone deficiency in Sweden compared with a random population sample assessed by QoL-AGHDA. Endocrinol Metab 1997; 4(Suppl B): 167
40. Badia X, Lucas A, Sanmarti A, Ulied A. One year follow-up of quality of life in adults with untreated growth hormone deficiency. Clin Endocrinol (Oxf) 1998; 49: 765-71
41. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BÅ. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995; 44: 1126-9
42. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, et al. Influences on quality of life in GH deficient adults and their effect on response to treatment. Clin Endocrinol (Oxf) 1999; in press
43. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993; 76: 1344-8
44. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkeback NE, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1: 1221-5